Thermo Fisher Scientific | TMO - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Abbott USD 4.27B 669M 2026-09
Agilent USD 475M 10M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Bio Techne USD 67.42M 41.91M 2026-06
Bio-Rad Laboratories USD 212M 400K 2026-06
Boston Scientific USD 1.68B 120M 2026-09
Bruker USD 226.5M 12.4M 2026-09
Charles River Laboratories USD 140.59M 88.31M 2026-09
Danaher USD 2.16B 87M 2026-09
Dentsply International USD 364M 13M 2026-06
Edwards Lifesciences USD 560.9M 300K 2026-09
General Electric Aerospace USD 1.09B 40M 2026-09
Henry Schein USD 819M 12M 2026-09
Illumina USD 281M 8M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
IQVIA Holdings USD 569M 5M 2026-09
Laboratory Of America USD 611.4M 34.2M 2026-09
Medtronic 3.2B 141M 2026-06
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Olympus JPY 125.03B 14.31B 2026-06
OraSure Technologies USD 13.21M 3.29M 2025-12
Quest Diagnostics USD 523M 6M 2026-09
Repligen USD 83.59M 6.97M 2026-09
Revvity USD 275.33M 3.25M 2026-09
Stryker USD 2.12B 32M 2026-06
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Veracyte USD 57.95M 2.25M 2026-09
Waters USD 398M 7M 2026-09
Zimmer Biomet Holdings USD 855M 56.6M 2026-09